The FDA lists BPC-157 among bulk drug substances that may present significant safety risks in compounding, citing concerns such as immune reactions, peptide-related impurities, and limited safety information
Why Tesamorelin Must Be Cycled: The Clinical Reason Behind the 3-Month Schedule Continuous, uninterrupted GHRH stimulation leads to receptor downregulation over time
Unless the reconstituted peptides stability requirements mandate refrigerated or frozen storage, in which case follow the reconstituted compounds specific storage temperature guidance
The total cost includes the price of the medication, plus a $25 monthly treatment plan fee that is added to the cost each month
BPC-157 stands for body protection compound-157
Unknown Long-Term Effects : Human clinical data on BPC-157 covers fewer than 30 participants across 3 published pilot studies as of 2026